DENTSPLY SIRONA (NASDAQ:XRAY – Free Report) had its price target lowered by Stifel Nicolaus from $41.00 to $35.00 in a report released on Wednesday morning, Benzinga reports. The firm currently has a hold rating on the medical instruments supplier’s stock. A number of other equities analysts also recently commented on the stock. Evercore ISI reduced […]
Banco Bilbao Vizcaya Argentaria S.A. raised its stake in DENTSPLY SIRONA Inc. (NASDAQ:XRAY – Free Report) by 774.7% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 51,650 shares of the medical instruments supplier’s stock after acquiring an additional 45,745 shares during the period. […]
Versor Investments LP acquired a new position in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY – Free Report) in the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund acquired 21,050 shares of the medical instruments supplier’s stock, valued at approximately $842,000. Several other hedge funds and other institutional […]
StockNews.com cut shares of DENTSPLY SIRONA (NASDAQ:XRAY – Free Report) from a buy rating to a hold rating in a research report released on Monday morning. A number of other equities research analysts also recently commented on the stock. Barrington Research reiterated an outperform rating and set a $51.00 price target on shares of DENTSPLY […]
Quantinno Capital Management LP grew its position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY – Free Report) by 13.3% in the 2nd quarter, according to its most recent disclosure with the SEC. The fund owned 45,362 shares of the medical instruments supplier’s stock after buying an additional 5,338 shares during the period. Quantinno Capital Management LP’s holdings […]